SELLAS Life Sciences SLS
NASDAQ SLS
$11.74 +0.41 (+3.62%)
At close: Oct 2, 2026 · 4:00 PM EDT

SELLAS Life Sciences (SLS) Price to FCF (2017)

Updated

SELLAS Life Sciences' (SLS) Price to FCF stood at 27.76 in Q3 2017, down 74.4% from the prior quarter.

Analysis

SELLAS Life Sciences (SLS) Price to FCF (2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 SELLAS Life Sciences 2.37 Bn 2.37 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2017 27.76
Jun 30, 2017 108.47
API Access

SELLAS Life Sciences Price to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-fcf&ticker=SLS&period=max&api_key=YOUR_API_KEY